Prompts winter weather advisories as cold air moves in Friday night

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading Medicare business.

The health care giant said Thursday that it had contacted the Department of Justice after reviewing media reports about investigations into certain elements of its business.

“(UnitedHealth) has a long record of responsible conduct and effective compliance,” the company said in a Securities and Exchange Commission filing.

Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government’s Medicare coverage program mostly for people ages 65 and over.

The company’s UnitedHealthcare business covers more than 8 million people as the nation’s largest provider of Medicare Advantage plans. The business 

 in recent quarters due to rising care use and rate cuts.

The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months.

The paper has since said that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments.

UnitedHealth said in the filing Thursday that it "has full confidence in its practices and is committed to working cooperatively with the Department throughout this process."

UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support.

 last year to come in third in the Fortune 500 list of biggest U.S. companies. Its share price topped $630 last fall to reach a new all-time high.

But the stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson 

 in midtown Manhattan on his way to the company’s annual investor meeting. A suspect, 

, has been charged in connection with the shooting.

In April, shares plunged some more after the company 

 due to a spike in health care use. A month later, former CEO 

, and the company withdrew its forecast entirely, saying that medical costs from new Medicare Advantage members were higher than expected.

The stock price was down more than 3%, or $10.73, to $281.78 Thursday afternoon. That represents a 55% drop from the all-time high it hit in November. Broader indexes were mixed.

UnitedHealth will report its second-quarter results next Tuesday.

Use the audio player above to listen to a conversation with Wall Street Journal reporter Anna Mathews with Minnesota Now host Nina Moini, produced by Alanna Elder.

Business and Economic News

Homepage

Shows

Minnesota Now with Nina Moini

The Associated Press

Author

Nina Moini

Host

Alanna Elder

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading Medicare business.


Live, down to earth, unscripted interviews that aim to connect, inform and entertain. Real people share real stories with Nina Moini. It’s journalism that doesn’t take itself too seriously and puts people first.

UnitedHealth says it is under a federal investigation and cooperating

Go Deeper.

Like this?